Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity

[1]  J. Heller,et al.  Coxiella burnetii seroprevalence in unvaccinated veterinary workers in Australia: Evidence to support Q fever vaccination , 2020, Zoonoses and public health.

[2]  Janine K. Tom,et al.  Tuning Subunit Vaccines with Novel TLR Triagonist Adjuvants to Generate Protective Immune Responses against Coxiella burnetii , 2019, The Journal of Immunology.

[3]  Yan Zhang,et al.  MHC-II-restricted, CD4+ T cell-dependent and -independent mechanisms are required for vaccine-induced protective immunity against Coxiella burnetii. , 2019, Infection and immunity.

[4]  G. Jensen,et al.  Molecular architecture, polar targeting and biogenesis of the Legionella Dot/Icm T4SS , 2019, Nature Microbiology.

[5]  R. Heinzen,et al.  Comparative virulence of diverse Coxiella burnetii strains , 2019, Virulence.

[6]  A. Sluder,et al.  Standardized guinea pig model for Q fever vaccine reactogenicity , 2018, PloS one.

[7]  Jun Liu,et al.  A Unique Cytoplasmic ATPase Complex Defines the Legionella pneumophila Type IV Secretion Channel , 2018, Nature Microbiology.

[8]  R. Heinzen,et al.  Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation , 2018, PLoS pathogens.

[9]  A. Sluder,et al.  Q-vaxcelerate: A distributed development approach for a new Coxiella burnetii vaccine , 2017, Human vaccines & immunotherapeutics.

[10]  R. Heinzen,et al.  Whole-Genome Sequence of Coxiella burnetii Nine Mile RSA439 (Phase II, Clone 4), a Laboratory Workhorse Strain , 2017, Genome Announcements.

[11]  D. Raoult,et al.  No Such Thing as Chronic Q Fever , 2017, Emerging infectious diseases.

[12]  J. Samuel,et al.  The SCID Mouse Model for Identifying Virulence Determinants in Coxiella burnetii , 2017, Front. Cell. Infect. Microbiol..

[13]  D. Raoult,et al.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change , 2016, Clinical Microbiology Reviews.

[14]  R. Heinzen,et al.  Right on Q: genetics begin to unravel Coxiella burnetii host cell interactions. , 2016, Future microbiology.

[15]  R. Heinzen,et al.  Complementation of Arginine Auxotrophy for Genetic Transformation of Coxiella burnetii by Use of a Defined Axenic Medium , 2016, Applied and Environmental Microbiology.

[16]  W. Heuwieser,et al.  Effect of a phase I Coxiella burnetii inactivated vaccine on body temperature and milk yield in dairy cows. , 2016, Journal of dairy science.

[17]  D. Wolfe,et al.  Vaccination against Q fever for biodefense and public health indications , 2014, Front. Microbiol..

[18]  M. Bonazzi,et al.  Galleria mellonella as an alternative model of Coxiella burnetii infection. , 2014, Microbiology.

[19]  M. Bonazzi,et al.  Identification of OmpA, a Coxiella burnetii Protein Involved in Host Cell Invasion, by Multi-Phenotypic High-Content Screening , 2014, PLoS pathogens.

[20]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[21]  V. Trouplin,et al.  Impaired stimulation of p38α-MAPK/Vps41-HOPS by LPS from pathogenic Coxiella burnetii prevents trafficking to microbicidal phagolysosomes. , 2012, Cell host & microbe.

[22]  Guoquan Zhang,et al.  Development of a Lipopolysaccharide-Targeted Peptide Mimic Vaccine against Q Fever , 2012, The Journal of Immunology.

[23]  R. Heinzen,et al.  Two Systems for Targeted Gene Deletion in Coxiella burnetii , 2012, Applied and Environmental Microbiology.

[24]  D. Ribaud,et al.  Assessment of vaccination by a phase I Coxiella burnetii-inactivated vaccine in goat herds in clinical Q fever situation. , 2012, FEMS immunology and medical microbiology.

[25]  Joshua S. Self,et al.  Virulence of pathogenic Coxiella burnetii strains after growth in the absence of host cells. , 2011, Vector borne and zoonotic diseases.

[26]  R. Heinzen,et al.  Dot/Icm Type IVB Secretion System Requirements for Coxiella burnetii Growth in Human Macrophages , 2011, mBio.

[27]  D. St Johnston,et al.  Supplementary Figure 5 , 2009 .

[28]  R. Heinzen,et al.  Isolation from Animal Tissue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth Medium , 2011, Applied and Environmental Microbiology.

[29]  H. Nagai,et al.  Type IVB Secretion Systems of Legionella and Other Gram-Negative Bacteria , 2011, Front. Microbio..

[30]  E. Hak,et al.  Effectiveness of the Q fever vaccine: a meta-analysis. , 2011, Vaccine.

[31]  A. Harmsen,et al.  Role of CD4+ and CD8+ T Cells in Clearance of Primary Pulmonary Infection with Coxiella burnetii , 2010, Infection and Immunity.

[32]  J. Samuel,et al.  Laboratory Maintenance of Coxiella burnetii , 2009, Current protocols in microbiology.

[33]  D. Kruszon-Moran,et al.  Seroprevalence of Q fever in the United States, 2003-2004. , 2009, The American journal of tropical medicine and hygiene.

[34]  J. Samuel,et al.  Coxiella burnetii Isolates Cause Genogroup-Specific Virulence in Mouse and Guinea Pig Models of Acute Q Fever , 2009, Infection and Immunity.

[35]  R. Heinzen,et al.  Coxiella type IV secretion and cellular microbiology. , 2009, Current opinion in microbiology.

[36]  R. Heinzen,et al.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii , 2009, Immunologic research.

[37]  Kelly P. Williams,et al.  Comparative Genomics Reveal Extensive Transposon-Mediated Genomic Plasticity and Diversity among Potential Effector Proteins within the Genus Coxiella , 2008, Infection and Immunity.

[38]  N. Dziuba,et al.  Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. , 2008, The American journal of tropical medicine and hygiene.

[39]  F. Schmidt.  Meta-Analysis , 2008 .

[40]  I. Vogiatzis,et al.  Q fever myocarditis. , 2008, Hippokratia.

[41]  J. Samuel,et al.  Mechanisms of Vaccine-Induced Protective Immunity against Coxiella burnetii Infection in BALB/c Mice1 , 2007, The Journal of Immunology.

[42]  B. Marmion.  Q fever: the long journey to control by vaccination , 2007, The Medical journal of Australia.

[43]  J. Samuel,et al.  Clinical and Pathologic Changes in a Guinea Pig Aerosol Challenge Model of Acute Q Fever , 2006, Infection and Immunity.

[44]  Søren Højsgaard,et al.  The R Package geepack for Generalized Estimating Equations , 2005 .

[45]  L. Semendric,et al.  Q Fever Research Group (QRG), Adelaide: Activities‐Exit Summary 1980–2004 , 2005, Annals of the New York Academy of Sciences.

[46]  T. Zusman,et al.  Additive Effect on Intracellular Growth by Legionella pneumophila Icm/Dot Proteins Containing a Lipobox Motif , 2005, Infection and Immunity.

[47]  P. Dufour,et al.  Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats. , 2005, Vaccine.

[48]  R. Heinzen,et al.  Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  T. Zusman,et al.  The Icm/Dot type-IV secretion systems of Legionella pneumophila and Coxiella burnetii. , 2005, FEMS microbiology reviews.

[50]  S. Akira,et al.  Lipopolysaccharide from Coxiella burnetii Is Involved in Bacterial Phagocytosis, Filamentous Actin Reorganization, and Inflammatory Responses through Toll-Like Receptor 41 , 2004, The Journal of Immunology.

[51]  T. Komiya,et al.  A seroepidemiological study of the risks of Q fever infection in Japanese veterinarians , 2004, European Journal of Epidemiology.

[52]  R. Weinstein,et al.  Q fever: a biological weapon in your backyard. , 2003, The Lancet. Infectious diseases.

[53]  H. Vordermeier,et al.  Modulation of the Bovine Delayed-Type Hypersensitivity Responses to Defined Mycobacterial Antigens by a Synthetic Bacterial Lipopeptide , 2003, Infection and Immunity.

[54]  Karen Yong,et al.  An economic evaluation of increased uptake in Q fever vaccination among meat and agricultural industry workers following implementation of the National Q Fever Management Program , 2003, Australian and New Zealand journal of public health.

[55]  C. Fraser,et al.  Complete genome sequence of the Q-fever pathogen Coxiella burnetii , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  T. Hoover,et al.  Chromosomal DNA Deletions Explain Phenotypic Characteristics of Two Antigenic Variants, Phase II and RSA 514 (Crazy), of the Coxiella burnetii Nine Mile Strain , 2002, Infection and Immunity.

[57]  M. Kawamura,et al.  Phase Variation Analysis of Coxiella burnetii during Serial Passage in Cell Culture by Use of Monoclonal Antibodies , 2002, Infection and Immunity.

[58]  I. Literák,et al.  Comparison of virulence of Coxiella burnetii isolates from bovine milk and from ticks. , 2001, Folia parasitologica.

[59]  Ľ. Škultéty,et al.  Phase variation of Coxiella burneti0i strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide , 2000, Journal of endotoxin research.

[60]  B. Marmion,et al.  Vaccine prophylaxis of Q fever: A follow‐up study of the efficacy of Q‐Vax (CSL) 1985‐1990 , 1994, The Medical journal of Australia.

[61]  D. Raoult,et al.  Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. , 1992, The American journal of medicine.

[62]  B. Vermeer.  Skin irritation and sensitization , 1991 .

[63]  A. Izzo,et al.  Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs , 1990, Epidemiology and Infection.

[64]  T. Hackstadt.  Steric hindrance of antibody binding to surface proteins of Coxiella burnetti by phase I lipopolysaccharide , 1988, Infection and immunity.

[65]  T. Hackstadt,et al.  Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii , 1988, Infection and immunity.

[66]  T. Hackstadt,et al.  Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model , 1987, Infection and immunity.

[67]  J. Williams,et al.  Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice , 1986, Infection and Immunity.

[68]  T. Hackstadt,et al.  Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity , 1985, Infection and immunity.

[69]  S. Schramek,et al.  Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia. , 1982, Bulletin of the World Health Organization.

[70]  A. Sibatani.  Paradigm change , 1981, Nature.

[71]  M. Peacock,et al.  Limits of rickettsial infectivity , 1978, Infection and immunity.

[72]  T Fredriksson,et al.  Severe psoriasis--oral therapy with a new retinoid. , 1978, Dermatologica.

[73]  S. Schramek,et al.  Characterization of an endotoxic lipopolysaccharide from Coxiella burnetii. , 1976, Acta virologica.

[74]  D. Lackman,et al.  THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE. , 1964, Journal of immunology.

[75]  E. Ribi,et al.  CONVERSION OF THE PHASE I ANTIGEN OF COXIELLA BURNETII TO HAPTEN BY PHENOL TREATMENT , 1963, Journal of bacteriology.

[76]  E. Ribi,et al.  Antigenic and Skin-Reactive Properties of Fractions of Coxiella Burnetii , 1962, The Journal of Immunology.

[77]  R. Březina,et al.  Study of the Antigenic Structure of Coxiella burneti. I. Extraction of Phase I Antigenic Component by Means of Trichloroacetic Acid. , 1962 .

[78]  D. Lackman,et al.  Intradermal sensitivity testing in man with a purified vaccine for Q fever. , 1962, American journal of public health and the nation's health.

[79]  P. Fiset,et al.  Phase variation of the Nine Mile and other strains of Rickettsia burneti. , 1956, Canadian journal of microbiology.

[80]  E. H. Lennette,et al.  Q fever in California. I. Observations on vaccination of human beings. , 1951, American journal of hygiene.

[81]  F. Robbins,et al.  Vaccination against Q fever. , 1947, Journal of bacteriology.

[82]  H. R. Cox,et al.  A filter-passing Infectious Agent isolated from Ticks. I. Isolation from Dermacentor andersoni, Reactions in Animals, and Filtration Experiments. , 1938 .